カテゴリ： MarketLine, カナダ, 企業調査

Emera Inc.：戦略・SWOT・企業財務分析

◆英語タイトル：Emera Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015213
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：62
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：カナダ
◆産業分野：エネルギー・装置
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Emera Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Emera Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Emera Inc. (Emera or ‘the company’) is an energy and services company that owns and invests in electricity generation, transmission and distribution, gas transmission, utility services, energy marketing and trading services, and other energy-related management services. The company operates in Canada, the US, and the Caribbean. It is headquartered in Nova Scotia, Canada and employed 3,454 people as on December 31, 2015.

Scope

- Detailed information on Emera Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Emera Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Emera Inc. including a breakdown and examination of key business segments
- Intelligence on Emera Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Emera Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Emera Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Emera Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Emera Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Emera Inc.: Company Overview
Emera Inc.: Overview and Key Facts
Emera Inc.: Overview
Emera Inc.: Key Facts
Emera Inc.: Key Employees
Emera Inc.: Key Employee Biographies
Emera Inc.: Major Products and Services
Emera Inc.: Company History
Emera Inc.: Management Statement
Emera Inc.: Locations and Subsidiaries
Emera Inc.: Key Competitors
Emera Inc.: Company Analysis
Emera Inc.: Business Description
Emera Inc.: SWOT Analysis
Emera Inc.: SWOT Overview
Emera Inc.: Strengths
Emera Inc.: Weaknesses
Emera Inc.: Opportunities
Emera Inc.: Threats
Emera Inc.: Corporate Financial Deals Activity
Emera Inc.: Financial Deals Overview
Emera Inc.: Targets and Partners
Emera Inc.: Top Deals 2013 – 2017YTD*
Emera Inc.: Advisors
Emera Inc.: Top Legal Advisors
Emera Inc.: Top Financial Advisors
Emera Inc.: Mergers and Acquisitions
Emera Inc.: Corporate Venturing
Emera Inc.: Capital Raising
Emera Inc.: Divestments
Emera Inc.: Recent Developments
Emera Inc.: News and Events Summary
Emera Inc.: Corporate Governance
Emera Inc.: Financial Performance
Emera Inc.: Regulatory and Legal Events
Emera Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Emera Inc.: Key Facts
Table 2: Emera Inc.: Key Employees
Table 3: Emera Inc.: Locations and Subsidiaries
Table 4: Emera Inc.: Key Competitors
Table 5: Emera Inc.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Emera Inc.: M&A Average Deal Size - Value (US$m)
Table 7: Emera Inc.: Targets and Partners
Table 8: Emera Inc.: Top Deals 2013 - 2017YTD*
Table 9: Emera Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Emera Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Emera Inc.: M&A Volume and Value Trend (2013 - YTD*2017)
Table 12: Emera Inc.: M&A Activity by Geography (2013 - YTD*2017)
Table 13: Emera Inc.: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 14: Emera Inc.: Corporate Venturing by Geography (2013 - YTD*2017)
Table 15: Emera Inc.: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 16: Emera Inc.: Capital Raising by Deal Type (2013 - YTD*2017)
Table 17: Emera Inc.: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 18: Emera Inc.: Divestments by Geography (2013 - YTD*2017)
Table 19: Emera Inc.: News and Events Summary
Table 20: Emera Inc.: Corporate Governance
Table 21: Emera Inc.: Financial Performance
Table 22: Emera Inc.: Regulatory and Legal Events
Table 23: Emera Inc.: Strategy and Operations

★海外企業調査レポート[Emera Inc.：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • President Energy PLC (PPC)：石油・ガス：M&Aディール及び事業提携情報
    Summary President Energy PLC (President) is an independent oil and gas exploration and production company. It focuses mainly on Argentina and Paraguay in South America. The company has a diverse portfolio of operated onshore producing and exploration assets. Its major assets include working interest …
  • Sonoma Pharmaceuticals Inc (SNOA)：製薬・医療：M&Aディール及び事業提携情報
    Summary Sonoma Pharmaceuticals Inc (Sonoma), formerly Oculus Innovative Sciences, is a pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for ad …
  • Karus Therapeutics Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Karus Therapeutics Ltd (Karus) is a designer and developer of molecule cancer therapies. The company provides treatment of a diverse range of solid and hematological cancers and small molecule drug. It develops two clinic-tracked programs potent and selective inhibitors of PI3K and HDAC for …
  • TriVascular Inc：医療機器：M&Aディール及び事業提携情報
    Summary TriVascular Inc (TriVascular), a subsidiary of Endologix Inc is a medical device company that researches, designs and manufactures technologies to provide optimal solutions for endovascular aortic repair. The company’s product comprise endovascular grafts and self-expanding stent grafts; ova …
  • American Rheinmetall Munitions, Inc.：企業の戦略・SWOT・財務情報
    American Rheinmetall Munitions, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Rheinmetall Munitions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Pine Cliff Energy Ltd (PNE)：企業の財務・戦略的SWOT分析
    Summary Pine Cliff Energy Ltd (Pine Cliff) is an oil and gas company that offers exploration, production, and development of natural gas, crude oil, and natural gas liquids. The company operates through its core areas such as Edson Assets, Central Assets, and Southern Assets. It acquired Hatton prop …
  • Qliance Medical Management Inc-製薬・医療分野：企業M&A・提携分析
    Summary Qliance Medical Management Inc (QMMI), a subsidiary of Qliance Medical Group is a healthcare service provider that provides primary and preventive care services. The company offers services such as health and wellness, chronic condition management, specialist care coordination, urgent care, …
  • Baoding Lightway Green Energy Technology Co Ltd：電力：M&Aディール及び事業提携情報
    Summary Baoding Lightway Green Energy Technology Co Ltd (Lightway Green), a subsidiary of LONGJITAIHE Group, is a vertically integrated solar module manufacturer. It specializes in the manufacture of high quality solar PV products, provides professional solutions and customer service. The company de …
  • Tsakos Energy Navigation Limited：企業の戦略・SWOT・財務分析
    Tsakos Energy Navigation Limited - Strategy, SWOT and Corporate Finance Report Summary Tsakos Energy Navigation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • CooperSurgical Inc-医療機器分野：企業M&A・提携分析
    Summary CooperSurgical Inc (CooperSurgical), a subsidiary of The Cooper Companies Inc is a medical device company that offers surgical instrument. The company offers surgical products, clinic and office products, labor and delivery products, and critical care products. Its surgical products include …
  • Cryo-Cell International Inc (CCEL)：企業の財務・戦略的SWOT分析
    Summary Cryo-Cell International Inc (Cryo-Cell) is a cord blood bank service provider. The company offers biotechnology services, collection and preservation of umbilical cord blood stem cells for family use. It provides services such as cord blood banking, cord tissue banking, cord blood and tissue …
  • The Hershey Co：企業の戦略・SWOT・財務情報
    The Hershey Co - Strategy, SWOT and Corporate Finance Report Summary The Hershey Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Commercial Bank International PSC：企業の戦略・SWOT・財務情報
    Commercial Bank International PSC - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank International PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Roka Bioscience Inc：医療機器：M&Aディール及び事業提携情報
    Summary Roka Bioscience Inc (Roka) is a manufacturer and distributor of molecular assays and instruments for food safety industry. The company offers products such as Atlas- automated molecular pathogen detection system, the listeria LSP detection assay, listeria monocytogenes Lmg2 detection assay, …
  • Intrusion Inc (INTZ)：企業の財務・戦略的SWOT分析
    Summary Intrusion Inc (Intrusion) is a technology company. The company offers network monitoring and analysis solutions. Its product portfolio includes Savant, TraceCop that enables identification of malicious and illegal activities, Secure Tap a suite of network tap products that enables deployment …
  • Storz Medical AG：企業の戦略的SWOT分析
    Storz Medical AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Adam & Company PLC：企業の戦略・SWOT・財務情報
    Adam & Company PLC - Strategy, SWOT and Corporate Finance Report Summary Adam & Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Stamps.com Inc. (STMP)：企業の財務・戦略的SWOT分析
    Stamps.com Inc. (STMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Apogenix AG：製薬・医療：M&Aディール及び事業提携情報
    Summary Apogenix AG (Apogenix) is a developer of immuno-oncology medicines for the treatment of oncological and malignant hematological diseases. The company’s pipeline drug candidates under clinical development include APG101, a CD95 ligand inhibitor for the treatment of glioblastoma and myelodyspl …
  • Zealand Pharma AS (ZEAL)：製薬・医療：M&Aディール及び事業提携情報
    Summary Zealand Pharma AS (Zealand) is a biotechnology company that discovers, designs and develops peptide based medicines that targets specialty diseases. The company’s marketed products comprise Lyxumia and Suliqua for the treatment of Type 2 diabetes and others for the treatment of obesity and f …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆